Komodo Health announced Monday that it will provide software and analytics technology to a network of patient advocacy groups to help improve earlier diagnoses, close gaps in care and acc...

Neurotechnology start-up IDUN Technologies presented data at the World Sleep Congress from a preliminary validation study of its mobile DRYODE Guardian system, a two-channel in-ear electroencephalo...

Digital health start-up Alimetry announced that it received the CE mark for its wearable Gastric Alimetry device to non-invasively diagnose gastric diseases such as functional dyspepsia, gastropare...

Alva Health’s continuous stroke monitor aims to expand the number of people who can benefit from existing solutions to treat the condition and significantly improve outcomes.&n...

Sidekick Health announced Thursday that it raised $55 million in Series B funding to accelerate the multi-chronic capabilities of its digital therapeutics platform and to continue growing ...

The FDA announced Friday that it issued an emergency-use authorisation (EUA) for Cue Health's COVID-19 test for home and over-the-counter (OTC) use, making it the first molecular diagnostic tes...

PicnicHealth and Komodo Health announced on Monday a partnership to support real-world evidence research programmes for complex illnesses such as multiple sclerosis and haemophilia. Under the...

Teladoc Health announced on Wednesday expanded capabilities for its Primary360 whole-person primary care of...

We break down the most popular healthtech reads from the past week. Resmed packs $1bn into outpatient software

Caris Life Sciences announced on Thursday that it entered into an exclusive collaboration agreement with the National Cancer Center Japan to provide its comprehensive molecular profiling in MONSTAR...

We break down the most popular healthtech reads from the past seven days. Medtronic slumps on macro impact

Ultromics announced Tuesday the FDA clearance of its artificial intelligence (AI)-based EchoGo Heart Failure solution for echocardiography to allow precise detection of heart failure...

Koneksa on Tuesday announced the start of a clinical study to determine how well at-home mobile spirometry with digital biomarkers stacks up against in-clinic spirometry wh...

Altoida's augmented reality (AR) app is able to identify individuals with early-stage Alzheimer's disease (AD) from healthy patients, according to study findings published in Nature Digital Medicin...

Quest Diagnostics is partnering with Google's Fitbit to study how wearable devices can improve metabolic health linked to several conditions, including diabetes and heart disease. Principal investi...

Seer Medical announced Monday that it received FDA 510(k) clearance of its Seer Home ambulatory monitoring system for the diagnosis of epilepsy via multi-day, video-based e...

With the advancement of genomic technologies comes better understanding of the human genome, better understanding of disease mechanisms and, ultimately, the transformation of healthcare t...

A real-world analysis of patients with type 2 diabetes who monitored both their blood glucose (BG) and blood pressure (BP) levels using Dario Health's mobile app revealed a "...

According to study findings published in The Journal of Pathology, analysing immune responses in the lymph nodes of women with triple-negative breast cancer can determine the likelihood of the dise...

Orexo announced Friday that the last participant has enrolled in a pivotal study of its digital therapeutic...

We break down the five most important and most read stories from the past seven days.  October’s VCs Devoted to virtual payvidor

Digital health start-up Cleerly on Monday said it raised $192 million in Series C financing, bringing its total fundraise to date to $248 million, including a

Altoida announced Thursday that its technology, which combines novel digital biomarkers with augmented reality (AR) and artificial intelligence (AI), will be used to provide more sen...

Tilak Healthcare announced on Wednesday that it is launching a pilot programme in the US with Novartis for OdySight, the former's mob...

Omniome doesn’t have any products on the market yet, but Pacbio believes its proprietary short-read sequencing technology will be a springboard into a much bigger, multi-billion-dol...

Closed Loop Medicine announced on Wednesday that it raised £13 million ($17.7million) to finance its personalised drug plus digital therapy (DTx) combination products, which are being develop...